BR9608731A - Uso de derivados de 1,2,4-triazol para produção de um medicamento para tratamento de câncer - Google Patents

Uso de derivados de 1,2,4-triazol para produção de um medicamento para tratamento de câncer

Info

Publication number
BR9608731A
BR9608731A BR9608731A BR9608731A BR9608731A BR 9608731 A BR9608731 A BR 9608731A BR 9608731 A BR9608731 A BR 9608731A BR 9608731 A BR9608731 A BR 9608731A BR 9608731 A BR9608731 A BR 9608731A
Authority
BR
Brazil
Prior art keywords
produce
cancer treatment
triazole derivatives
treatment drug
drug
Prior art date
Application number
BR9608731A
Other languages
English (en)
Inventor
Ames Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9608731A publication Critical patent/BR9608731A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9608731A 1995-06-07 1996-05-22 Uso de derivados de 1,2,4-triazol para produção de um medicamento para tratamento de câncer BR9608731A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/473,819 US5770616A (en) 1995-06-07 1995-06-07 Pharmaceutical composition for inhibiting the growth of cancers
PCT/US1996/007444 WO1996040119A1 (en) 1995-06-07 1996-05-22 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers

Publications (1)

Publication Number Publication Date
BR9608731A true BR9608731A (pt) 1999-06-29

Family

ID=23881121

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608731A BR9608731A (pt) 1995-06-07 1996-05-22 Uso de derivados de 1,2,4-triazol para produção de um medicamento para tratamento de câncer

Country Status (20)

Country Link
US (4) US5770616A (pt)
EP (1) EP0831814A1 (pt)
JP (1) JPH11508233A (pt)
KR (1) KR19990022619A (pt)
CN (1) CN1190344A (pt)
AR (1) AR003138A1 (pt)
AU (1) AU707077B2 (pt)
BR (1) BR9608731A (pt)
CA (1) CA2223967A1 (pt)
CZ (1) CZ391797A3 (pt)
HU (1) HUP9802677A3 (pt)
IL (1) IL118425A (pt)
NO (1) NO975662L (pt)
NZ (1) NZ308391A (pt)
PL (1) PL324107A1 (pt)
RU (1) RU2177316C2 (pt)
SK (1) SK168597A3 (pt)
TR (2) TR199701534T1 (pt)
WO (1) WO1996040119A1 (pt)
ZA (1) ZA964374B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6200992B1 (en) * 1995-06-07 2001-03-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US5770616A (en) * 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US5908855A (en) * 1996-07-16 1999-06-01 The Procter & Gamble Company Compositions for treating viral infections
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
CN100334084C (zh) * 2005-04-26 2007-08-29 武汉大学 联三唑化合物及其制备方法和用途
US20070116643A1 (en) * 2005-07-01 2007-05-24 Concert Pharmaceuticals Inc. Novel aryloxypropanamines
AU2006318476A1 (en) * 2005-11-23 2007-05-31 Auspex Pharmaceuticals, Inc. Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079062A (en) * 1974-11-18 1978-03-14 Janssen Pharmaceutica N.V. Triazole derivatives
US4160838A (en) * 1977-06-02 1979-07-10 Janssen Pharmaceutica N.V. Antimicrobial and plant-growth-regulating triazole derivatives
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US4490540A (en) * 1981-09-14 1984-12-25 Janssen Pharmaceutica N.V. (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives
DE3238903A1 (de) * 1982-10-21 1984-04-26 Bayer Ag, 5090 Leverkusen Antivirales mittel
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
DE3511409A1 (de) * 1985-03-29 1986-10-02 Basf Ag, 6700 Ludwigshafen Herstellung von arzneimitteln gegen viruserkrankungen
DE3511411A1 (de) * 1985-03-29 1986-10-02 Basf Ag, 6700 Ludwigshafen Verwendung von azolylmethyloxiranen zur bekaempfung von viralen erkrankungen
US5211736A (en) * 1988-05-09 1993-05-18 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
DE3837463A1 (de) * 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPH02257929A (ja) * 1989-03-09 1990-10-18 Makutaa Kk 生体透過率測定器
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
RO114129B1 (ro) 1991-09-02 1999-01-29 Yamanouchi Pharmaceutical Co., Ltd. Derivaţi aminici terţiari substituiţi cu triazolil
US5360612A (en) * 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5656615A (en) 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
ZA962880B (en) 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US5665713A (en) 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962879B (en) 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
AU714056B2 (en) 1995-04-12 1999-12-16 Uaf Technologies And Research Llc A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
US5629341A (en) 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
NZ305784A (en) 1995-04-12 2001-03-30 Procter & Gamble Benzimidazole containing medicaments for treating cancers, tumors and viral infections
MX9707809A (es) 1995-06-07 1998-01-31 Procter & Gamble Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
KR19990022617A (ko) 1995-06-07 1999-03-25 데이비드 엠 모이어 백혈병 치료용 약제의 제조를 위한 벤즈이미다졸의 용도
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6200992B1 (en) 1995-06-07 2001-03-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US5770616A (en) * 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
PL324905A1 (en) 1995-08-03 1998-06-22 Procter & Gamble Application of griseofulvin in carcinoma development inhibition
US5908855A (en) 1996-07-16 1999-06-01 The Procter & Gamble Company Compositions for treating viral infections
IL123095A0 (en) 1995-08-04 1998-09-24 Procter & Gamble Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (es) 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment

Also Published As

Publication number Publication date
NO975662D0 (no) 1997-12-05
IL118425A0 (en) 1996-09-12
IL118425A (en) 2001-05-20
HUP9802677A2 (hu) 1999-08-30
CZ391797A3 (cs) 1998-05-13
JPH11508233A (ja) 1999-07-21
AU5801996A (en) 1996-12-30
NO975662L (no) 1998-02-09
AR003138A1 (es) 1998-07-08
CA2223967A1 (en) 1996-12-19
AU707077B2 (en) 1999-07-01
HUP9802677A3 (en) 1999-11-29
US5770616A (en) 1998-06-23
CN1190344A (zh) 1998-08-12
TR199701534T1 (xx) 1998-02-21
NZ308391A (en) 2000-05-26
SK168597A3 (en) 1998-12-02
TR199801323T2 (xx) 1998-09-21
RU2177316C2 (ru) 2001-12-27
WO1996040119A1 (en) 1996-12-19
US5872142A (en) 1999-02-16
US6025377A (en) 2000-02-15
PL324107A1 (en) 1998-05-11
KR19990022619A (ko) 1999-03-25
ZA964374B (en) 1997-02-17
US6228876B1 (en) 2001-05-08
EP0831814A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
BR9608731A (pt) Uso de derivados de 1,2,4-triazol para produção de um medicamento para tratamento de câncer
BR9609093A (pt) Uso de bis-1,2,4-triazóis para produção de um medicamento para tratamento de cãncer
GR3032486T3 (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents
DE59601328D1 (de) Chirurgischer Wundsperrer
DK0914118T3 (da) Substituerede 3,5-diphenyl-1,2,4-triazoler og deres anvendelse som farmaceutiske metalkompleksdannere
DE69626167D1 (de) Chirurgischer Retraktor
BR9700829A (pt) Uso de interferon consensus humano para a produção de um medicamento
PT864327E (pt) Utilizacao de derivados de pirimidina para a preparacao de um medicamento para a prevencao do cancro
BR9609987A (pt) Uso de derivados do 1H-1,2,4-triazol para a inibição do crescimento de cânceres
HUP9900905A3 (en) Use of vitamin d4 derivatives for treating cancer
BR9609920A (pt) Uso de griseofulvina para inibir o crescimento de cânceres
BR9606856A (pt) Uso dermatológico de derívados de vitamina d
AU4942393A (en) Use of ribose in the preparation of a drug for use in the treatment of decrease in body performance, in particular organ insufficiency
GB9508823D0 (en) Drug Derivatives
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
HK1014938A1 (en) Oxazolidinone derivatives, their preparation and therapeutical use
DE59602953D1 (de) Fungizide wirkstoffkombinationen
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
NZ320323A (en) Amine derivatives of epipodophyllotoxin 2", 3"- dideoxyglycosides, preparation and use thereof as a drug and for treating cancer
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
IL124751A0 (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives preparation and therapeutical use thereof
EE9800163A (et) Uued kinoksaliindiooni derivaadid, nende valmistamine ja ravimitena kasutamine
HUP9801596A3 (en) Use of azole compounds for preparing pharmaceutical compositions useful for the treatment of fungal infections, new azole derivatives and pharmaceutical compositions containing them
ES1032715Y (es) Capsula de uso personal para contener medicamentos.
RU95118900A (ru) Противоопухолевое средство

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]